PHARMACY

FDA approves Diuril generic

BY Alaric DeArment

SCHAUMBURG, Ill. The Food and Drug Administration has approved the first generic version of an injected drug for hypertension.

APP Pharmaceuticals announced the approval of chlorothiazide sodium, which it plans to launch in fourth quarter 2009.

 

The drug is a generic version of Lundbeck Pharmaceuticals’ Diuril, a diuretic used for treating hypertension and fluid retention in patients with congestive heart failure, cirrhosis of the liver, kidney disorders and edema.

 

Diuril had sales of $51 million in 2008, according to IMS Health data.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

FDA using pharmaceutical market research to track influenza treatment

BY Alaric DeArment

BRIDGEWATER, N.J. The Food and Drug Administration is using prescription data from a pharmaceutical market research firm to track treatment of A-H1N1 and other influenza viruses.

Wolters Kluwer Pharma Solutions announced Wednesday that the FDA would use its weekly updates to see who was using the four most popular oral antiviral drugs — Roche’s Tamiflu (oseltamivir), GlaxoSmithKline’s Relenza (zanamivir), Forest Labs’ Flumadine (rimantadine) and Endo Pharmaceuticals’ Symmetrel (amantadine), the latter two of which are available in generic form — and identify clusters where large numbers of people use them.

“The FDA is using our prescription data as a means of tracking the treatment of populations affected by flu outbreaks, including the H1N1 virus, and the specific medications being used to treat them,” Wolters Kluwer Pharma Solutions CEO Mark Spiers said in a statement. “The data are typically not more than five days old upon delivery.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

NACDS pharmacy affairs chief Rosato honored as distinguished Temple alumna

BY Jim Frederick

ALEXANDRIA, Va. Edith Rosato, SVP pharmacy affairs for the National Association of Chain Drug Stores and president of the NACDS Foundation, was honored Friday for her achievements and leadership in the pharmacy profession.

The honor came from Rosato’s alma mater, Temple University, which named the pharmacy veteran with the distinguished 2009 Gallery of Success Award. Rosato is a 1982 graduate of the Temple University School of Pharmacy.

Each of Temple’s 17 schools and colleges annually honor two alumni who serve as inspirations to the next generation of Temple graduates. “Ms. Rosato brings over 30 years of leadership and experience in the pharmaceutical industry to her position” at NACDS, Temple noted in announcing the award. “As a registered pharmacist, she has a deep commitment to the advancement of community pharmacy and advocates for the important and integral role for pharmacists in the delivery of quality health care to patients.”

Gallery of Success award recipients, including Rosato, will have their photos and biographies displayed on the Temple University campus in Philadelphia throughout the academic year.

“Edith’s alma mater should be commended for making an outstanding selection for this high honor,” noted NACDS president and CEO Steve Anderson. “Everyone at NACDS congratulates her on her achievements and looks forward to her continued success.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?